Aventis Pasteur Issues Statement on Availability of Influenza Vaccines
SWIFTWATER, Pa. -- For the upcoming influenza season, Aventis Pasteur expects to supply more than 52 million doses of influenza vaccine to the U.S. market. This amount exceeds last year's supply by more than nine million doses and is the largest U.S. production ever by a single manufacturer. Our customers began receiving shipments in early August and all will receive at least a partial shipment of their order by the end of
September. The balance of shipments will be completed as originally announced
to our customers.
Aventis Pasteur has experienced robust demand for Fluzone Influenza
Virus Vaccine this season through a pre-booking campaign that began last
December. In addition, the companys vaccine production experienced strong yields that enabled it to maximize the amount of vaccine it can supply and to accelerate its shipping schedule.
Due to the delays being experienced by another manufacturer, Aventis
Pasteur will work closely with the Centers for Disease Control and
Prevention (CDC) to best manage its remaining supply once existing customer
commitments are fulfilled. Until these plans are finalized, the company will establish
a waiting list of providers who request new or additional vaccine shipments. Aventis Pasteur is also assessing the possibility of increasing production.
Source: Aventis Pasteur
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
